📰 Multaq Tablets News
Multaq Tablets News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multaq Tablets. Real-time updates on events, politics, business and more.
January 10, 2022
Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today.
January 10, 2022
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Multaq Tablets, 400 mg, of Sanofi-Aventis U.S. LLC (Sanofi-Aventis).
January 10, 2022
NEW DELHI, Jan 10: Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market generic Dronedarone tablets, which is used to reduce risk of hospitalisation for atrial fibrillation, in the American market. The company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for its medication in strength of 400 mg, the drug maker said in a statement. The tentatively approved ANDA i...